1. Home
  2. IPW vs BLRX Comparison

IPW vs BLRX Comparison

Compare IPW & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

HOLD

Current Price

$7.51

Market Cap

10.3M

ML Signal

HOLD

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$2.90

Market Cap

12.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPW
BLRX
Founded
2018
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
12.6M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
IPW
BLRX
Price
$7.51
$2.90
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$19.00
AVG Volume (30 Days)
135.2K
25.8K
Earning Date
02-12-2026
11-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,151,725.00
$12,735,000.00
Revenue This Year
$149.67
N/A
Revenue Next Year
$15.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$2.30
52 Week High
$34.65
$14.70

Technical Indicators

Market Signals
Indicator
IPW
BLRX
Relative Strength Index (RSI) 39.01 38.99
Support Level $10.01 $2.81
Resistance Level $12.01 $3.10
Average True Range (ATR) 1.28 0.18
MACD -0.43 -0.01
Stochastic Oscillator 0.42 16.56

Price Performance

Historical Comparison
IPW
BLRX

About IPW iPower Inc.

iPower Inc is a United States-based online retailer and supplier of consumer home, pet, garden, outdoor, and consumer electronics products. It also operates as a provider of value-added ecommerce services for third-party products and brands. The company's capabilities include a spectrum of online channels, fulfillment capacity, a network of warehouses serving the U.S., last-mile delivery partners, and a differentiated business intelligence platform. The company's sales channels currently include Amazon Vendor, Amazon 3P, Walmart.com, TikTok, Temu, and other marketplaces, as well as its own e-commerce websites, such as simpledeluxe.com and more. Additionally, it is developing in-house branded products and through supply chain partners, which include iPower, Simple Deluxe, and other brands.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: